D
Recursion Pharmaceuticals, Inc. RXRX
$4.94 $0.163.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 64.60M 59.79M 58.84M 65.18M 49.64M
Total Other Revenue -- -- -- -- --
Total Revenue 64.60M 59.79M 58.84M 65.18M 49.64M
Cost of Revenue 498.07M 432.40M 359.66M 327.90M 322.10M
Gross Profit -433.47M -372.61M -300.82M -262.71M -272.47M
SG&A Expenses 216.35M 201.53M 178.29M 132.64M 124.09M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 714.42M 633.93M 537.95M 460.54M 446.19M
Operating Income -649.83M -574.14M -479.11M -395.36M -396.55M
Income Before Tax -649.12M -575.28M -464.79M -382.95M -380.29M
Income Tax Expenses 16.00K -507.00K -1.13M -5.20M -5.36M
Earnings from Continuing Operations -649.13 -574.78 -463.66 -377.75 -374.93
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -649.13M -574.78M -463.66M -377.75M -374.93M
EBIT -649.83M -574.14M -479.11M -395.36M -396.55M
EBITDA -586.50M -525.69M -442.62M -364.26M -365.08M
EPS Basic -1.79 -1.78 -1.66 -1.55 -1.64
Normalized Basic EPS -1.12 -1.11 -1.04 -0.98 -1.04
EPS Diluted -1.79 -1.78 -1.66 -1.55 -1.64
Normalized Diluted EPS -1.12 -1.11 -1.04 -0.98 -1.04
Average Basic Shares Outstanding 1.44B 1.26B 1.10B 983.96M 915.70M
Average Diluted Shares Outstanding 1.44B 1.26B 1.10B 983.96M 915.70M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --